▶ 調査レポート

パンクレリパーゼのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Pancrelipase Market Insights and Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。パンクレリパーゼのグローバル市場インサイト・予測(~2028年) / Global Pancrelipase Market Insights and Forecast to 2028 / QY2203B05040資料のイメージです。• レポートコード:QY2203B05040
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、72ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のパンクレリパーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパンクレリパーゼの世界市場のxxx%を占める「カプセル剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「大人用」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のパンクレリパーゼの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのパンクレリパーゼ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのパンクレリパーゼ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

パンクレリパーゼのグローバル主要メーカーには、Abbott、Janssen、Aptalis、DCIなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

パンクレリパーゼ市場は、種類と用途によって区分されます。世界のパンクレリパーゼ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
カプセル剤、錠剤

【用途別セグメント】
大人用、子供用

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- パンクレリパーゼ製品概要
- 種類別市場(カプセル剤、錠剤)
- 用途別市場(大人用、子供用)
- 調査の目的
・エグゼクティブサマリー
- 世界のパンクレリパーゼ販売量予測2017-2028
- 世界のパンクレリパーゼ売上予測2017-2028
- パンクレリパーゼの地域別販売量
- パンクレリパーゼの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別パンクレリパーゼ販売量
- 主要メーカー別パンクレリパーゼ売上
- 主要メーカー別パンクレリパーゼ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(カプセル剤、錠剤)
- パンクレリパーゼの種類別販売量
- パンクレリパーゼの種類別売上
- パンクレリパーゼの種類別価格
・用途別市場規模(大人用、子供用)
- パンクレリパーゼの用途別販売量
- パンクレリパーゼの用途別売上
- パンクレリパーゼの用途別価格
・北米市場
- 北米のパンクレリパーゼ市場規模(種類別、用途別)
- 主要国別のパンクレリパーゼ市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのパンクレリパーゼ市場規模(種類別、用途別)
- 主要国別のパンクレリパーゼ市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のパンクレリパーゼ市場規模(種類別、用途別)
- 主要国別のパンクレリパーゼ市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のパンクレリパーゼ市場規模(種類別、用途別)
- 主要国別のパンクレリパーゼ市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのパンクレリパーゼ市場規模(種類別、用途別)
- 主要国別のパンクレリパーゼ市場規模(トルコ、サウジアラビア)
・企業情報
Abbott、Janssen、Aptalis、DCI
・産業チェーン及び販売チャネル分析
- パンクレリパーゼの産業チェーン分析
- パンクレリパーゼの原材料
- パンクレリパーゼの生産プロセス
- パンクレリパーゼの販売及びマーケティング
- パンクレリパーゼの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- パンクレリパーゼの産業動向
- パンクレリパーゼのマーケットドライバー
- パンクレリパーゼの課題
- パンクレリパーゼの阻害要因
・主な調査結果

Pancrelipase (CAS 53608-75-6) is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. Pancrelipase is used to replace these enzymes when the body does not have enough of its own. Certain medical conditions can cause this lack of enzymes, including cystic fibrosis, chronic inflammation of the pancreas, or blockage of the pancreatic ducts.
Market Analysis and Insights: Global Pancrelipase Market
Due to the COVID-19 pandemic, the global Pancrelipase market size is estimated to be worth US$ 1164.7 million in 2022 and is forecast to a readjusted size of US$ 1499.4 million by 2028 with a CAGR of 4.3% during the review period. Fully considering the economic change by this health crisis, Capsule accounting for % of the Pancrelipase global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Adult segment is altered to an % CAGR throughout this forecast period.
The market concentrate is high and in the world there are mainly four companies such as Abbott, Janssen, Aptalis and DCI. Abbott is the biggest manufacturer in the world and taking 37% of the global production. USA is the biggest manufacturing region in the world for Abbott is the biggest manufacturer in the world with the main factory based in USA. Europe also is a main manufacturing region for the famous company Janssen manufactures pancrelipase in Europe.
Global Pancrelipase Scope and Segment
Pancrelipase market is segmented by Type and by End User. Players, stakeholders, and other participants in the global Pancrelipase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by End User for the period 2017-2028.
Segment by Type
Capsule
Tablet
Segment by End User
Adult
Children
By Company
Abbott
Janssen
Aptalis
DCI
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Pancrelipase Product Introduction
1.2 Market by Type
1.2.1 Global Pancrelipase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by End User
1.3.1 Global Pancrelipase Market Size Growth Rate by End User, 2017 VS 2021 VS 2028
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pancrelipase Sales Estimates and Forecasts 2017-2028
2.2 Global Pancrelipase Revenue Estimates and Forecasts 2017-2028
2.3 Global Pancrelipase Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pancrelipase Sales by Region
2.4.1 Global Pancrelipase Sales by Region (2017-2022)
2.4.2 Global Sales Pancrelipase by Region (2023-2028)
2.5 Global Pancrelipase Revenue by Region
2.5.1 Global Pancrelipase Revenue by Region (2017-2022)
2.5.2 Global Pancrelipase Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pancrelipase Sales by Manufacturers
3.1.1 Global Top Pancrelipase Manufacturers by Sales (2017-2022)
3.1.2 Global Pancrelipase Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pancrelipase in 2021
3.2 Global Pancrelipase Revenue by Manufacturers
3.2.1 Global Pancrelipase Revenue by Manufacturers (2017-2022)
3.2.2 Global Pancrelipase Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pancrelipase Revenue in 2021
3.3 Global Pancrelipase Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pancrelipase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pancrelipase Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pancrelipase Sales by Type
4.1.1 Global Pancrelipase Historical Sales by Type (2017-2022)
4.1.2 Global Pancrelipase Forecasted Sales by Type (2023-2028)
4.1.3 Global Pancrelipase Sales Market Share by Type (2017-2028)
4.2 Global Pancrelipase Revenue by Type
4.2.1 Global Pancrelipase Historical Revenue by Type (2017-2022)
4.2.2 Global Pancrelipase Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pancrelipase Revenue Market Share by Type (2017-2028)
4.3 Global Pancrelipase Price by Type
4.3.1 Global Pancrelipase Price by Type (2017-2022)
4.3.2 Global Pancrelipase Price Forecast by Type (2023-2028)
5 Market Size by End User
5.1 Global Pancrelipase Sales by End User
5.1.1 Global Pancrelipase Historical Sales by End User (2017-2022)
5.1.2 Global Pancrelipase Forecasted Sales by End User (2023-2028)
5.1.3 Global Pancrelipase Sales Market Share by End User (2017-2028)
5.2 Global Pancrelipase Revenue by End User
5.2.1 Global Pancrelipase Historical Revenue by End User (2017-2022)
5.2.2 Global Pancrelipase Forecasted Revenue by End User (2023-2028)
5.2.3 Global Pancrelipase Revenue Market Share by End User (2017-2028)
5.3 Global Pancrelipase Price by End User
5.3.1 Global Pancrelipase Price by End User (2017-2022)
5.3.2 Global Pancrelipase Price Forecast by End User (2023-2028)
6 North America
6.1 North America Pancrelipase Market Size by Type
6.1.1 North America Pancrelipase Sales by Type (2017-2028)
6.1.2 North America Pancrelipase Revenue by Type (2017-2028)
6.2 North America Pancrelipase Market Size by End User
6.2.1 North America Pancrelipase Sales by End User (2017-2028)
6.2.2 North America Pancrelipase Revenue by End User (2017-2028)
6.3 North America Pancrelipase Market Size by Country
6.3.1 North America Pancrelipase Sales by Country (2017-2028)
6.3.2 North America Pancrelipase Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pancrelipase Market Size by Type
7.1.1 Europe Pancrelipase Sales by Type (2017-2028)
7.1.2 Europe Pancrelipase Revenue by Type (2017-2028)
7.2 Europe Pancrelipase Market Size by End User
7.2.1 Europe Pancrelipase Sales by End User (2017-2028)
7.2.2 Europe Pancrelipase Revenue by End User (2017-2028)
7.3 Europe Pancrelipase Market Size by Country
7.3.1 Europe Pancrelipase Sales by Country (2017-2028)
7.3.2 Europe Pancrelipase Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pancrelipase Market Size by Type
8.1.1 Asia Pacific Pancrelipase Sales by Type (2017-2028)
8.1.2 Asia Pacific Pancrelipase Revenue by Type (2017-2028)
8.2 Asia Pacific Pancrelipase Market Size by End User
8.2.1 Asia Pacific Pancrelipase Sales by End User (2017-2028)
8.2.2 Asia Pacific Pancrelipase Revenue by End User (2017-2028)
8.3 Asia Pacific Pancrelipase Market Size by Region
8.3.1 Asia Pacific Pancrelipase Sales by Region (2017-2028)
8.3.2 Asia Pacific Pancrelipase Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pancrelipase Market Size by Type
9.1.1 Latin America Pancrelipase Sales by Type (2017-2028)
9.1.2 Latin America Pancrelipase Revenue by Type (2017-2028)
9.2 Latin America Pancrelipase Market Size by End User
9.2.1 Latin America Pancrelipase Sales by End User (2017-2028)
9.2.2 Latin America Pancrelipase Revenue by End User (2017-2028)
9.3 Latin America Pancrelipase Market Size by Country
9.3.1 Latin America Pancrelipase Sales by Country (2017-2028)
9.3.2 Latin America Pancrelipase Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pancrelipase Market Size by Type
10.1.1 Middle East and Africa Pancrelipase Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pancrelipase Revenue by Type (2017-2028)
10.2 Middle East and Africa Pancrelipase Market Size by End User
10.2.1 Middle East and Africa Pancrelipase Sales by End User (2017-2028)
10.2.2 Middle East and Africa Pancrelipase Revenue by End User (2017-2028)
10.3 Middle East and Africa Pancrelipase Market Size by Country
10.3.1 Middle East and Africa Pancrelipase Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pancrelipase Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Pancrelipase Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Janssen
11.2.1 Janssen Corporation Information
11.2.2 Janssen Overview
11.2.3 Janssen Pancrelipase Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Janssen Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Recent Developments
11.3 Aptalis
11.3.1 Aptalis Corporation Information
11.3.2 Aptalis Overview
11.3.3 Aptalis Pancrelipase Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Aptalis Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aptalis Recent Developments
11.4 DCI
11.4.1 DCI Corporation Information
11.4.2 DCI Overview
11.4.3 DCI Pancrelipase Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 DCI Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 DCI Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pancrelipase Industry Chain Analysis
12.2 Pancrelipase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pancrelipase Production Mode & Process
12.4 Pancrelipase Sales and Marketing
12.4.1 Pancrelipase Sales Channels
12.4.2 Pancrelipase Distributors
12.5 Pancrelipase Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pancrelipase Industry Trends
13.2 Pancrelipase Market Drivers
13.3 Pancrelipase Market Challenges
13.4 Pancrelipase Market Restraints
14 Key Findings in The Global Pancrelipase Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pancrelipase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Pancrelipase Market Size Growth Rate by End User, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Pancrelipase Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pancrelipase Sales by Region (2017-2022) & (M Units)
Table 7. Global Pancrelipase Sales Market Share by Region (2017-2022)
Table 8. Global Pancrelipase Sales by Region (2023-2028) & (M Units)
Table 9. Global Pancrelipase Sales Market Share by Region (2023-2028)
Table 10. Global Pancrelipase Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Pancrelipase Revenue Market Share by Region (2017-2022)
Table 12. Global Pancrelipase Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Pancrelipase Revenue Market Share by Region (2023-2028)
Table 14. Global Pancrelipase Sales by Manufacturers (2017-2022) & (M Units)
Table 15. Global Pancrelipase Sales Share by Manufacturers (2017-2022)
Table 16. Global Pancrelipase Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Pancrelipase Revenue Share by Manufacturers (2017-2022)
Table 18. Pancrelipase Price by Manufacturers (2017-2022) &(USD/K Unit)
Table 19. Global Pancrelipase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Pancrelipase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancrelipase as of 2021)
Table 21. Pancrelipase Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pancrelipase Product Offered
Table 23. Date of Manufacturers Enter into Pancrelipase Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 26. Global Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 27. Global Pancrelipase Sales Share by Type (2017-2022)
Table 28. Global Pancrelipase Sales Share by Type (2023-2028)
Table 29. Global Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Pancrelipase Revenue Share by Type (2017-2022)
Table 32. Global Pancrelipase Revenue Share by Type (2023-2028)
Table 33. Pancrelipase Price by Type (2017-2022) & (USD/K Unit)
Table 34. Global Pancrelipase Price Forecast by Type (2023-2028) & (USD/K Unit)
Table 35. Global Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 36. Global Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 37. Global Pancrelipase Sales Share by End User (2017-2022)
Table 38. Global Pancrelipase Sales Share by End User (2023-2028)
Table 39. Global Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 40. Global Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 41. Global Pancrelipase Revenue Share by End User (2017-2022)
Table 42. Global Pancrelipase Revenue Share by End User (2023-2028)
Table 43. Pancrelipase Price by End User (2017-2022) & (USD/K Unit)
Table 44. Global Pancrelipase Price Forecast by End User (2023-2028) & (USD/K Unit)
Table 45. North America Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 46. North America Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 47. North America Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 50. North America Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 51. North America Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 52. North America Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 53. North America Pancrelipase Sales by Country (2017-2022) & (M Units)
Table 54. North America Pancrelipase Sales by Country (2023-2028) & (M Units)
Table 55. North America Pancrelipase Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Pancrelipase Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 58. Europe Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 59. Europe Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 62. Europe Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 63. Europe Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 64. Europe Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 65. Europe Pancrelipase Sales by Country (2017-2022) & (M Units)
Table 66. Europe Pancrelipase Sales by Country (2023-2028) & (M Units)
Table 67. Europe Pancrelipase Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Pancrelipase Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 70. Asia Pacific Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 71. Asia Pacific Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 74. Asia Pacific Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 75. Asia Pacific Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 76. Asia Pacific Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 77. Asia Pacific Pancrelipase Sales by Region (2017-2022) & (M Units)
Table 78. Asia Pacific Pancrelipase Sales by Region (2023-2028) & (M Units)
Table 79. Asia Pacific Pancrelipase Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Pancrelipase Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 82. Latin America Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 83. Latin America Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 86. Latin America Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 87. Latin America Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 88. Latin America Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 89. Latin America Pancrelipase Sales by Country (2017-2022) & (M Units)
Table 90. Latin America Pancrelipase Sales by Country (2023-2028) & (M Units)
Table 91. Latin America Pancrelipase Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Pancrelipase Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Pancrelipase Sales by Type (2017-2022) & (M Units)
Table 94. Middle East and Africa Pancrelipase Sales by Type (2023-2028) & (M Units)
Table 95. Middle East and Africa Pancrelipase Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Pancrelipase Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Pancrelipase Sales by End User (2017-2022) & (M Units)
Table 98. Middle East and Africa Pancrelipase Sales by End User (2023-2028) & (M Units)
Table 99. Middle East and Africa Pancrelipase Revenue by End User (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Pancrelipase Revenue by End User (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Pancrelipase Sales by Country (2017-2022) & (M Units)
Table 102. Middle East and Africa Pancrelipase Sales by Country (2023-2028) & (M Units)
Table 103. Middle East and Africa Pancrelipase Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Pancrelipase Revenue by Country (2023-2028) & (US$ Million)
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Major Businesses
Table 107. Abbott Pancrelipase Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 108. Abbott Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Abbott Recent Developments
Table 110. Janssen Corporation Information
Table 111. Janssen Description and Major Businesses
Table 112. Janssen Pancrelipase Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 113. Janssen Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Janssen Recent Developments
Table 115. Aptalis Corporation Information
Table 116. Aptalis Description and Major Businesses
Table 117. Aptalis Pancrelipase Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 118. Aptalis Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Aptalis Recent Developments
Table 120. DCI Corporation Information
Table 121. DCI Description and Major Businesses
Table 122. DCI Pancrelipase Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 123. DCI Pancrelipase Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. DCI Recent Developments
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Pancrelipase Distributors List
Table 128. Pancrelipase Customers List
Table 129. Pancrelipase Market Trends
Table 130. Pancrelipase Market Drivers
Table 131. Pancrelipase Market Challenges
Table 132. Pancrelipase Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Pancrelipase Product Picture
Figure 3. Global Pancrelipase Market Share by Type in 2021 & 2028
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Pancrelipase Market Share by End User in 2021 & 2028
Figure 6. Adult
Figure 7. Children
Figure 8. Pancrelipase Report Years Considered
Figure 9. Global Pancrelipase Sales 2017-2028 (M Units)
Figure 10. Global Pancrelipase Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Pancrelipase Revenue 2017-2028 (US$ Million)
Figure 12. Global Pancrelipase Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Pancrelipase Sales Market Share by Region (2017-2022)
Figure 14. Global Pancrelipase Sales Market Share by Region (2023-2028)
Figure 15. North America Pancrelipase Sales YoY (2017-2028) & (M Units)
Figure 16. North America Pancrelipase Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Pancrelipase Sales YoY (2017-2028) & (M Units)
Figure 18. Europe Pancrelipase Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Pancrelipase Sales YoY (2017-2028) & (M Units)
Figure 20. Asia-Pacific Pancrelipase Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Pancrelipase Sales YoY (2017-2028) & (M Units)
Figure 22. Latin America Pancrelipase Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Pancrelipase Sales YoY (2017-2028) & (M Units)
Figure 24. Middle East & Africa Pancrelipase Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Pancrelipase Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Pancrelipase in the World: Market Share by Pancrelipase Revenue in 2021
Figure 27. Global Pancrelipase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Pancrelipase Sales Market Share by Type (2017-2028)
Figure 29. Global Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 30. Global Pancrelipase Sales Market Share by End User (2017-2028)
Figure 31. Global Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 32. North America Pancrelipase Sales Market Share by Type (2017-2028)
Figure 33. North America Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 34. North America Pancrelipase Sales Market Share by End User (2017-2028)
Figure 35. North America Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 36. North America Pancrelipase Sales Share by Country (2017-2028)
Figure 37. North America Pancrelipase Revenue Share by Country (2017-2028)
Figure 38. U.S. Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Pancrelipase Sales Market Share by Type (2017-2028)
Figure 41. Europe Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 42. Europe Pancrelipase Sales Market Share by End User (2017-2028)
Figure 43. Europe Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 44. Europe Pancrelipase Sales Share by Country (2017-2028)
Figure 45. Europe Pancrelipase Revenue Share by Country (2017-2028)
Figure 46. Germany Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 47. France Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Pancrelipase Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Pancrelipase Sales Market Share by End User (2017-2028)
Figure 54. Asia Pacific Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 55. Asia Pacific Pancrelipase Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Pancrelipase Revenue Share by Region (2017-2028)
Figure 57. China Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 60. India Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Pancrelipase Sales Market Share by Type (2017-2028)
Figure 68. Latin America Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Pancrelipase Sales Market Share by End User (2017-2028)
Figure 70. Latin America Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 71. Latin America Pancrelipase Sales Share by Country (2017-2028)
Figure 72. Latin America Pancrelipase Revenue Share by Country (2017-2028)
Figure 73. Mexico Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Pancrelipase Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Pancrelipase Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Pancrelipase Sales Market Share by End User (2017-2028)
Figure 79. Middle East and Africa Pancrelipase Revenue Market Share by End User (2017-2028)
Figure 80. Middle East and Africa Pancrelipase Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Pancrelipase Revenue Share by Country (2017-2028)
Figure 82. Turkey Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Pancrelipase Revenue (2017-2028) & (US$ Million)
Figure 85. Pancrelipase Value Chain
Figure 86. Pancrelipase Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed